Latest news
Low-cost MS treatment shown to be as effective as standard therapy in landmark NEJM trial - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 15:15:33 GMTLatigo Biotherapeutics Announces New England Journal of Medicine Publication of Positive LTG-001 Abdominoplasty Clinical Trial Results in Moderate-to-Severe Acute Pain - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMT